Study finds your morning coffee could help with type 2 diabetes

Roasted coffee may do more than just wake you up in the morning.

Scientists from Kunming Institute of Botany, Chinese Academy of Sciences, have discovered several new coffee compounds that inhibit α-glucosidase, a key enzyme linked to type 2 diabetes.

Some of these coffee-derived molecules were even more potent than a common anti-diabetic drug. The study also introduced a faster, greener way to uncover health-boosting compounds in complex foods.

The compounds were found to strongly inhibit α-glucosidase, an enzyme that plays a central role in breaking down carbohydrates during digestion.

Since this enzyme directly affects how quickly sugars enter the bloodstream, the discovery points to possible new functional food ingredients aimed at managing type 2 diabetes.

The discovery was made using more advanced analytical methods: nuclear magnetic resonance (NMR) and liquid chromatography-mass spectrometry (LC-MS/MS).

After the complex tests, it was analyzed that although the three caffaldehydes differed in their fatty acid components (palmitic, stearic, and arachidic acids), all showed notable α-glucosidase inhibition.

They indicated stronger activity than the comparison drug acarbose.

It was found that while they shared similar fragment patterns, these molecules contained different fatty acids (magaric, octadecenoic, and nonadecanoic acids).

Searches of existing compound databases confirmed that these substances had not been reported before.

This could lead to new opportunities to develop coffee-based functional foods or nutraceuticals that support glucose control and may help manage diabetes.